x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Leading Beyond The Lab

97% of our listeners don"t realise they aren"t followed, please double check, thank you!The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find

science life sciences

All Episodes

57:44

Will the Drug Work? Engineering a New Future for...

Leading Beyond The Lab ·

2026/03/03

90% of our listeners don't realise they aren't subscribed - please check!What if we could predict whether a drug will work, before it ever reaches a patient?This week, in another episode of Leading Beyond the Lab, we host a co-guest episode featuring Nik Sharma, CEO & Co-Founder of BioCortex, a trained neurologist with years of experience spanning clinical medicine, ALS research, academia (Cambridge, NIH) and more. And Muhannad Alomari, CTO & Co-Founder, with over a decade of experience

en

1:01:01

A Single Injection set to Eliminate Cancer? CEO of...

Leading Beyond The Lab ·

2026/02/24

What if a single injection could teach the immune system to eliminate cancer, and keep it away?This week, in another episode of Leading Beyond the Lab, Lawrence Rose sits down with Paul Peter Tak, MD, PhD, FMedSci, President & CEO of Candel Therapeutics, one of the most quietly compelling stories in cancer immunotherapy today.With over 30 years of experience spanning academic medicine, clinical immunology, rheumatology, oncology, and global pharmaceutical leadership, Paul Peter brings a rare

en

41:05

Is AI About to Collapse the Cost of Healthcare — Or...

Leading Beyond The Lab ·

2026/02/03

If AI is collapsing the cost of healthcare — are we on the brink of a historic breakthrough… or another bubble?This week on Leading Beyond the Lab, we sit down with @Edward Kliphuis, Partner at @Sofinnova Partners, one of Europe’s leading life-sciences venture capital firms.With over 20 years of experience spanning venture capital, digital health, tech-bio investing, and global life-sciences strategy, Edward has been at the forefront of investing where biology, computation, and healthcare collide.In

en

28:30

Parkinson’s Breakthrough Could Be Just Around the...

Leading Beyond The Lab ·

2026/01/29

From science fiction to clinical reality. What happens when cell therapy moves from promise to proof in patients who have run out of options?This week on Leading Beyond the Lab, Lawrence Rose sat down with Amit Rakhit, Chief Medical Officer at BlueRock Therapeutics, to explore how regenerative medicine, leadership, and culture intersect at the most pivotal stages of biotech development.A physician by training, Amit has built his career across large pharma and early stage biotech, including

en

43:46

How Smart Capital Is Shaping the Future of Biotech -...

Leading Beyond The Lab ·

2026/01/20

97% of our viewers don't realise they aren't followed, please double check, thank you!What does it really take to back and build world-class biotech companies from idea to FDA approval?This week on Leading Beyond the Lab, Lawrence Rose sat down with Jonathan Tobin, Partner at Brandon Capital, to explore what truly drives success in life-science venture capital.With over 20 years' experience spanning biotech investment, company creation, board leadership, and early-stage venture building, Jonathan

en

45:03

Nikhil Thatte On Investing In Best In Class Biotech...

Leading Beyond The Lab ·

2026/01/06

This episode is a masterclass in how world-class life sciences investors think about risk, conviction, and real patient impact.This week on Leading Beyond The Lab, Lawrence Rose sat down with Nikhil Thatte, Partner at Lumira Ventures, a leading Canadian life sciences venture capital firm, with over a decade of experience backing transformative biotech and medtech companies across North America.In this conversation, Nikhil shares how Lumira Ventures has built a top-quartile VC track record over

en

41:56

How NodThera’s NLRP3 Marks A New Era for Obesity...

Leading Beyond The Lab ·

2025/12/18

Cardio-metabolic diseases are the world’s biggest killer. But what if the next generation of treatments could change everything?This week on Leading Beyond The Lab, Lawrence Rose sat down with Jyothis George, CMO of Nodthera, and a global thought leader in the obesity space, shaping the future of cardio-metabolic and inflammatory disease innovation. Jyothis has led global programs across GLP-1, SGLT2, PCSK9 and now the emerging NLRP3 inhibitor class. His work spans companies such as Novo Nordisk,

en

51:37

How To Get Investment from Joey Mason | 25 Years In...

Leading Beyond The Lab ·

2025/12/09

25 years of life sciences venture experience in one episode.This week on Leading Beyond The Lab, @Lawrence Rose sat down with @Joey Mason, a venture investor with 25 years of experience across venture debt, venture capital and company building. Joey’s background spans senior roles with @Claret Capital Partners, @Sofinnova Partners, and earlier positions in investment banking and CRO services. His track record includes multiple successful exits, advising boards, working across Medtech, Biotech,

en

45:29

How Syncona built a $1Billion Dollar NAV Portfolio -...

Leading Beyond The Lab ·

2025/12/02

🤔 What does it really take to build a biotech that survives the clinical gauntlet and scales into a global business?🎬 This week on Leading Beyond The Lab, Lawrence Rose sat down with Roel Bulthuis, Managing Partner and Head of Investments at Syncona Limited. Roel has spent his career building, funding and scaling European biotech companies end-to-end, supporting high-performing teams from inception through clinical development, commercial launch and manufacturing scale-up. Along the way he

en

35:02

CEO of LEO Pharma Reveals Their IPO Strategy:...

Leading Beyond The Lab ·

2025/11/25

A once-in-a-century transformation, and the leader driving it.This week, in one of our biggest episode of Leading Beyond the Lab yet, we sit down with Christophe Bourdon, CEO of LEO Pharma, a company valued in the multi-billion-euro range and entering one of the most defining chapters in its 100-year history.With over 25+ years of global biopharma leadership experience, spanning pivotal roles at Amgen, Sanofi, and Orphazyme, Christophe brings a rare combination of commercial excellence, turnaround

en

39:49

Building a High-Impact Biotech Investment Engine -...

Leading Beyond The Lab ·

2025/11/18

What does it take to shape a high-impact biotech investment portfolio - and do it under a medical charity mandate?This week we sit down with Clare Terlouw, Head of LifeArc Ventures, whose 20+ year career spans investment banking, biotech company building, and leading venture teams focused on health innovation. With a unique perspective at the intersection of science, capital, and patient impact, Clare shares a candid and optimistic view of the evolving biotech landscape in the UK and beyond.In this

en

34:42

Is Nuclear Medicine Becoming Next Big Breakthrough in...

Leading Beyond The Lab ·

2025/09/19

If you're not paying attention to nuclear medicine, Danielle Meyrick will change that in under five minutes.This week, we sit down with Dr. Danielle Meyrick, Director and Co-Founder at EPIC Theranostics, to explore the meteoric rise of nuclear medicine and radiotheranostics. With over 20 years of experience spanning academia, biotech, and hospital environments, Danielle is uniquely positioned as both a scientific pioneer and commercial strategist. Her career has spanned from launching

en

39:47

Normunity's Breakthrough Cancer Drug the World Hasn't...

Leading Beyond The Lab ·

2025/09/09

Two of the most influential minds in immuno-oncology walk into a biotech… and build something that could change everything.Dr. Rachel Humphrey (CEO) and Dr. Melinda Merchant (CMO) of Normunity are two of the most seasoned and respected leaders in oncology drug development, with a combined 45+ years of experience across big pharma, biotech, and translational science. Rachel led the development of Yervoy® (ipilimumab) at BMS, Imfinzi® (durvalumab) at AstraZeneca, and Nexavar® (sorafenib) at Bayer,

en

32:42

How Maxion’s KnotBody® Platform Is Changing the Way...

Leading Beyond The Lab ·

2025/09/02

Dr. Arndt Schottelius, CEO of Maxion Therapeutics, is a physician-scientist with a standout career across Genentech, MorphoSys, Kymab, and now at one of the UK’s most promising biotech companies. At Maxion, he leads a team pioneering KnotBody technology - an innovative approach to targeting ion channels and GPCRs, long considered “undruggable” with biologics. Arndt brings more than 25 years of experience across translational science, drug development and leadership in global R&D. His conviction,

en

47:43

From Clinic to Billion-Dollar Breakthroughs:...

Leading Beyond The Lab ·

2025/08/26

If you want to understand what it really takes to build and lead a successful biotech, this episode is for you.Dr. Christopher Morabito, Chief Medical Officer at Astria Therapeutics, joins us to share hard-won lessons from 25 years in rare disease, oncology, and immunology. But this isn’t a career retrospective - it’s a deep dive into the mindset, strategies, and leadership habits that drive biotech success.In this episode, Chris reveals:How to make tough go/no-go decisions when the data isn’t

en

41:24

Needle in a Haystack Antibody Unlocking A Fundamental...

Leading Beyond The Lab ·

2025/08/18

If you're in biotech, immunology, or drug development - this is the episode you’ve been waiting for.We’re joined by Dr. Bhaskar Srivastava, Chief Medical Officer at Triveni Bio, whose career has spanned over 10 years across J&J, Nimbus, and now Triveni Bio, one of the most ambitious autoimmune biotech startups on the scene.In this episode, Bhaskar dives deep into:· How Triveni is building a first-in-class pipeline targeting the kallikrein system - a bold bet to treat severe skin and inflammatory

en

44:48

Mara Aspinall: The Former CEO Now Funding the...

Leading Beyond The Lab ·

2025/08/07

If you care about the future of genomics, diagnostics, and biotech investing, you can’t miss this episode.We’re joined by Mara Aspinall, Partner at Illumina Ventures, a trailblazer with over 30 years of leadership in diagnostics and eight years in venture capital funding groundbreaking genomics companies.In this episode, Mara reveals:The next wave of diagnostics, from liquid biopsies to home testing and new AI-driven tools.Hard-won lessons from leading Genzyme Genetics, Roche Tissue Diagnostics, and

en

40:16

Building Biotech in Saudi Arabia: An Investor’s View

Leading Beyond The Lab ·

2025/07/31

To anyone interested in life science VC investment – you need to watch this.In this episode, we’re joined by Dr. Sascha Berger, a biotech investment director based in Saudi Arabia and a very experienced life science investor globally. With nearly two decades in the industry, he’s seen breakthroughs, pivots, and billion-dollar transactions.He reveals:Saudi Arabia’s high-stakes plan to become a global biotech superpower by 2040 - and why it could disrupt the industry as we know it.The real role of a

en

24:09

Tomoko Maeda-Chubachi: Dermatology Leader, Fractional...

Leading Beyond The Lab ·

2025/06/05

In this episode, we sit down with Dr. Tomoko Maeda-Chubachi - a global leader in dermatology drug development and biotech innovation:Dr. Maeda-Chubachi serves as fractional Chief Medical Officer at various startups focusing on dermatology indications.20+ years experience in the pharmaceutical industry, Dr. Maeda-Chubachi has held senior roles at major companies like Pfizer, Eli Lilly, and GSK. Her expertise spans the entire drug development process, from early-phase trials to regulatory

en

31:04

Nick Reder: TechBio Leadership, 3D AI Spatial Biology

Leading Beyond The Lab ·

2025/05/29

In this episode, we sit down with Nicholas Reder, who’s pushing the boundaries in AI-driven spatial tissue analysis, with a mix of experience and insights:Nick is the Founder & CEO at Alpenglow Biosciences, pioneers in AI-powered 3D spatial biology that transforms how we see and understand tissue biopsies.10+ years in translational research, with degrees in biochem, epidemiology, and medicine – plus a residency and fellowship in pathology at the University of Washington.Co-developed a

en

31 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter